positive opinion

September 25, 2020September 25, 2020

Tecentriq-Avastin Combo Recommended for EU Approval for Liver Cancer

News

Tecentriq (atezolizumab), in combination with Avastin (bevacizumab), has been recommended for approval in the European Union as a first-line treatment for adults with advanced hepatocellular carcinoma (HCC), the most common ... Read more

March 29, 2017March 29, 2017

CHMP Recommends Opdivo Be Approved in EU to Treat Head and Neck Squamous Cell Cancer

News

The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency, has issued a positive opinion that recommends Opdivo (nivolumab) be approved to treat people with squamous cell ... Read more